Search Results 1631-1640 of 19487 for Myocardium

1. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

   ... myocardial infarction or unstable angina in the 6 months prior to screening). 7. Any moderate-to-severe pulmonary disease or difficulty taking inhaled drugs ...

2. Axicabtagene Ciloleucel Versus Standard Of Care Therapy As First-Line Therapy In High-Risk Large B-Cell Lymphoma - Mayo Clinic

   History of myocardial infarction, cardiac angioplasty or stenting, unstable angina, New York Heart Association Class II or greater congestive heart failure ...

3. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Recent myocardial infarction (< 1 month); Uncontrolled infection; Infection with HIV/AIDS. No other active primary malignancy requiring treatment or that ...

4. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

   Myocardial infarction less than 6 months before start of study drug 4. Anti-arrhythmic therapy (beta blockers are permitted) 5. Any unstable ischemic ...

5. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

   Absence of history of myocardial infarction =< 6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening ...

6. An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies - Mayo Clinic

   History of clinically significant or uncontrolled cardiac disease including unstable angina, acute myocardial infarction, New York Heart Association Class III ...

7. Comparing ESG to ESG with APC - Mayo Clinic

   Subjects with severe cardiopulmonary disease or other serious organic disease which might include known history of coronary artery disease, myocardial ...

8. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

   Significant history of uncontrolled cardiac disease defined as uncontrolled hypertension; unstable angina; myocardial infarction within the last 4 months; or ...

9. SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy - Mayo Clinic

   Myocardial infarction ≤ 6 months prior to first day of study drug treatment; 5. Unstable angina pectoris or serious uncontrolled cardiac arrhythmia. - Any ...

10. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

    History of myocardial infarction ≤ 180 days prior to registration; Congestive heart failure requiring use of ongoing maintenance therapy for life ...